help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, L. V. B.
Right arrow Articles by Davison, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, L. V. B.
Right arrow Articles by Davison, K.
(American Journal of Pathology. 1999;154:1017-1022.)
© 1999 American Society for Investigative Pathology


Technical Advance

Multiplex Western Blotting System for the Analysis of Muscular Dystrophy Proteins

Louise V. B. Anderson and Keith Davison

From the Neurobiology Department, University Medical School, Framlington Place, Newcastle upon Tyne, United Kingdom

A multiplex system of Western blotting is presented in which most of the current muscular dystrophy proteins can be analyzed simultaneously on one pair of blots. This represents a significant improvement in efficiency and cost for this type of analysis. The final diagnosis is more quickly achieved in patients where several possible diagnoses are indicated after clinical appraisal, and those with unusual presentations may be quickly resolved. The method uses a biphasic polyacrylamide gel system, which enables the corresponding blot to be probed simultaneously with a cocktail of monoclonal antibodies. The gel is optimized so that large proteins of more than 200 kd (eg, dystrophin, dysferlin, and myosin heavy chain) can be analyzed in the top part, while smaller proteins under 150 kd (eg, calpain 3, the 80-kd fragment of laminin {alpha}2 chain, all of the sarcoglycans, and caveolin 3) are separated in the lower phase. This basic system could be used for different combinations of antibodies as new muscular dystrophy proteins are identified and require examination. In addition, analysis of the laminin {alpha}2 chain of merosin showed that this protein was expressed as a doublet or triplet set of bands in many patients with active muscle pathology. This may indicate the existence of an embryonic isoform, which is re-expressed in regenerating fibers.





This article has been cited by other articles:


Home page
BrainHome page
F. L. M. Norwood, C. Harling, P. F. Chinnery, M. Eagle, K. Bushby, and V. Straub
Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population
Brain, November 1, 2009; 132(11): 3175 - 3186.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
E. J. Groen, R. Charlton, R. Barresi, L. V. Anderson, M. Eagle, J. Hudson, M. S. Koref, V. Straub, and K. M. D. Bushby
Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A
Brain, December 1, 2007; 130(12): 3237 - 3249.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. Illa, N. De Luna, R. Dominguez-Perles, R. Rojas-Garcia, C. Paradas, J. Palmer, C. Marquez, P. Gallano, and E. Gallardo
Symptomatic dysferlin gene mutation carriers: Characterization of two cases
Neurology, April 17, 2007; 68(16): 1284 - 1289.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. Huang, S. H. Laval, A. van Remoortere, J. Baudier, C. Benaud, L. V. B. Anderson, V. Straub, A. Deelder, R. R. Frants, J. T. den Dunnen, et al.
AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration
FASEB J, March 1, 2007; 21(3): 732 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. de Luna, E. Gallardo, M. Soriano, R. Dominguez-Perles, C. de la Torre, R. Rojas-Garcia, J. M. Garcia-Verdugo, and I. Illa
Absence of Dysferlin Alters Myogenin Expression and Delays Human Muscle Differentiation "in Vitro"
J. Biol. Chem., June 23, 2006; 281(25): 17092 - 17098.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. C. Brown, S. Torelli, M. Brockington, Y. Yuva, C. Jimenez, L. Feng, L. Anderson, I. Ugo, S. Kroger, K. Bushby, et al.
Abnormalities in {alpha}-Dystroglycan Expression in MDC1C and LGMD2I Muscular Dystrophies
Am. J. Pathol., February 1, 2004; 164(2): 727 - 737.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. T. Cooper, H. P. Lo, and K. N. North
Single section Western blot: Improving the molecular diagnosis of the muscular dystrophies
Neurology, July 8, 2003; 61(1): 93 - 97.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Poppe, L. Cree, J. Bourke, M. Eagle, L.V.B. Anderson, D. Birchall, M. Brockington, M. Buddles, M. Busby, F. Muntoni, et al.
The phenotype of limb-girdle muscular dystrophy type 2I
Neurology, April 22, 2003; 60(8): 1246 - 1251.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Aartsma-Rus, A. A.M. Janson, W. E. Kaman, M. Bremmer-Bout, J. T. den Dunnen, F. Baas, G.-J. B. van Ommen, and J. C.T. van Deutekom
Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients
Hum. Mol. Genet., April 15, 2003; 12(8): 907 - 914.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. G. De Angelis, O. Sthandier, B. Berarducci, S. Toso, G. Galluzzi, E. Ricci, G. Cossu, and I. Bozzoni
Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells
PNAS, July 9, 2002; 99(14): 9456 - 9461.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Yamada, F. Saito, H. Fukuta-Ohi, D. Zhong, A. Hase, K. Arai, A. Okuyama, R. Maekawa, T. Shimizu, and K. Matsumura
Processing of {beta}-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex
Hum. Mol. Genet., July 1, 2001; 10(15): 1563 - 1569.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Fanin, E. Pegoraro, C. Matsuda-Asada, R.H. Brown Jr., and C. Angelini
Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy
Neurology, March 13, 2001; 56(5): 660 - 665.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
Y. Torrente, J.-P Tremblay, F. Pisati, M. Belicchi, B. Rossi, M. Sironi, F. Fortunato, M. El Fahime, M. G. D'Angelo, N. J. Caron, et al.
Intraarterial Injection of Muscle-Derived Cd34+Sca-1+ Stem Cells Restores Dystrophin in mdx Mice
J. Cell Biol., January 22, 2001; 152(2): 335 - 348.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P. Dinçer, Z. Akçören, E. Demir, I. Richard, O. Sancak, G. Kale, E. Tan, J A. Urtizberea, and J. S Beckmann
A cross section of autosomal recessive limb-girdle muscular dystrophies in 38 families
J. Med. Genet., May 1, 2000; 37(5): 361 - 367.
[Abstract] [Full Text]


Home page
Hum Mol GenetHome page
K. M. D. Bushby
The limb-girdle muscular dystrophies--multiple genes,multiple mechanisms
Hum. Mol. Genet., September 1, 1999; 8(10): 1875 - 1882.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. M. D. Bushby
Making sense of the limb-girdle muscular dystrophies
Brain, August 1, 1999; 122(8): 1403 - 1420.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.